Transparency Market Research Announced Report Title "Inhalation & Nasal Spray Generic Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" And Its Full Database.
Albany, NY -- (SBWIRE) -- 10/19/2015 -- Generic drugs are drugs that are not associated with any company or a brand name and are subject to regulation of countries where they are dispensed. According to US FDA generic medicines are drugs that are identical or within an acceptable bioequivalent range with respect to pharmacokinetics and pharmacodynamics properties of branded drugs. More than 75% of the respiratory prescription drugs are delivered using inhalation or nasal spray technology. High revenue generator drugs are undoubtedly attracting the interest of generic drug manufacturers due to low cost of manufacturing. Though the advantages may show a promising future for generic drug device manufactures, it does possess several delivery challenges such as incorporation of ozone friendly devices that contain hydrofluoroalkane and phasing out of CFC's in metered dose inhalers.Some generic inhalers such as Advair have been approved in the EU, but these are generally branded products that use proprietary inhalation devices and are, therefore, not pure generics. In US manufacturing of generic MDIs are banned since 2008.
Request For Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1922
The scenario for generic drugs with respect to nasal spray and generic drugs is likely to change as in April 2013, US FDA posted its first individual product guidance for metered dose inhaler, albuterol sulphate. Again in September 2013, similar product guidance for fluticasone and salmeterol combination product used in treating asthma and chronic bronchitis were announced. Both of the guidance programs were organized by FDA office of generic products. Various generic drugs that are used as inhalers includes Nasonex (mometasone furoate), Flixonase (fluticasone propionate), Rhinocort (budesonide), Nasacort (triamcinolone acetonide) and Omnaris (ciclesonide). Some of the generic drugs used as nasal spray includes Fluticasone used for treating allergic conditions and Riociguat used for treating chronic thromboembolic pulmonary hypertension.
Market for inhalation & nasal spray generic drugs market seems promising for Asia-pacific due to rapidly aging demographics with 25% of population above 55 years of age and low purchasing power of consumers. In India due to patent cessations of bestseller drugs such as Advair from GlaxoSmithKline generic drug manufacturers are expected to actively participate in the production of generic version of these products. Indian companies are also ready with generic version of biotech drugs. Therefore, India and other Asian countries will be able to maintain a large generic market. In Europe, market for generic products are also restricted due to measures implemented in context with financial and economic crisis such as omission of most of generic drugs from reimbursement policies and introduction of tendering system for medicines in ambulatory care.The new health care lawsin United States to block the production of generic drugs in US creates a huge demand and prospecting future for Indian generic inhalers and nasal spray manufacturers.
Some of the leading players in inhalation & nasal spray generic drugs includes Apotex Inc., Cipla Ltd., Nephron Pharmaceuticals, Teva Pharmaceuticals Industries etc.
Browse Full Report With TOC: http://www.transparencymarketresearch.com/inhalation-nasal-spray-generic-drugs.html
About Transparency Market Research (TMR)
Transparency Market Research (TMR) is a next-generation provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Transparency Market Research
90 State Street,
Albany NY - 12207